TFDA-2024-0051-V151

Type IA variation for application TFDA-2024-0051. Type IA variation: Container Closure Change for Kcluximab — minor update

Variation Number
TFDA-2024-0051-V151
Type
Type IA
Application
TFDA-2024-0051
Change
CHG-2022-0151
Status
Draft
Fee
€4,101
Submitted
2022-08-26
Approved
—
Description

Type IA variation: Container Closure Change for Kcluximab — minor update